Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.32 USD
Change Today +0.01 / 0.43%
Volume 193.0
BOTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 9:30 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas D. Richman M.D.

Member of Scientific Advisory Board, Biota Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 99 board members in 8 different organizations across 12 different industries.

See Board Relationships
----

Background*

Dr. Douglas D. Richman, MD, is Professor of Pathology and Medicine at the University of California, San Diego School of Medicine and Chief of the Virology Section, Professor and Director of the Research Center for AIDS and HIV Infection at the San Diego VA Medical Center. Dr. Richman has investigated HIV disease and pathogenesis for the past 20 years and was the first to identify HIV drug resistance. He is also a virologist and practicing physician with the Veterans ...

Read Full Background

Corporate Headquarters*

2500 Northwinds Parkway
Alpharetta, Georgia 30009

United States

Phone: 678-221-3343
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
Stanford University
BA
Dartmouth College
Post-Doctoral Training
Harvard University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BOTA:US $2.32 USD +0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John M. Gill CPAChief Executive Officer, President and Director
PharmAthene, Inc.
--
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Anthony S. Marucci M.B.A.Founder, Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
$814.1K
Peter Mørch Eriksen BBAChief Executive Officer and Administration Director
BioPorto A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
$1.2M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.